The hedge fund sold out its stake in drug giant Pfizer ( PFE) in the quarter, as it expects cuts in future government reimbursements for branded pharmaceuticals will hurt revenue. Also weighing on the shares are concerns about the recent disclosure of additional government investigations into Pfizer's marketing practices.

Also in the third quarter, Greenlight sold its stake in oil-industry giant BP ( BP) over fear of falling energy prices. The hedge fund ended a multiyear short position in Amedisys ( AMED), a home health and hospice company.

Einhorn spent a good part of the investors' letter eviscerating the business model and accounting methods of Green Mountain Coffee Roasters ( GMCR), in which his fund has a substantial short position. Green Mountain reports earnings after the close of trading today.

>>To see these stocks in action, visit the 3 New Investment Ideas From Greenlight's Einhorn portfolio on Stockpickr.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

If you liked this article you might like

Comcast Dodges Big Social, Moves Watchable In-House

Rolling Stone Stake Could Fetch as Much as $80 Million

Hulu Threatens Landmark Networks With Prestigious Emmy Win

Weekend Box Office: 'Mother!' Flops With F Rating, 'It' Smashes Records

Why Entercom Communications Is a Buy: Cramer's Top Takeaways